Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy
Vincent Javaugue, Léa Dufour-Nourigat, Éstelle Desport, Audrey Sibille, Bruno Moulin, Pierre Bataille, Pascal Bindi, Cyril Garrouste, Christophe Mariat, Lionel Karlin, M. Nouvier, Jean‐Michel Goujon, Viviane Gnemmi, Jean‐Paul Fermand, Guy Touchard, Frank Bridoux
Topics & Concepts
GlomerulopathyCohortChemotherapyMedicineTerm (time)clone (Java method)PathologyOncologyInternal medicineGlomerulonephritisKidneyBiologyGeneticsGenePhysicsQuantum mechanicsAmyloidosis: Diagnosis, Treatment, OutcomesRenal Diseases and GlomerulopathiesIgG4-Related and Inflammatory Diseases